Biologics Spine Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia byJosh SandbergApril 11, 2023
Biologics Top Stories Induce Biologics Announces Launch of NMP Cancellous Strips byJosh SandbergFebruary 28, 2023
Biologics Top Stories Comparing the Cellular Effects of Bone Graft Materials: Nanosurfaces vs. Bioglass byJosh SandbergFebruary 22, 2023
Biologics Top Stories Mechanisms of Action for Biologically Active Bone Graft Materials byJosh SandbergNovember 8, 2022
Biologics Top Stories Types of Synthetic Bone Graft Products: Active vs. Passive Materials byJosh SandbergOctober 5, 2022
Biologics Regulatory Spine Ventris Medical Receives 510(k) Clearance for Amplify® Standalone Bone Graft Putty and Bone Graft Extender byJosh SandbergSeptember 14, 2022
Biologics Top Stories Cerapedics Completes Enrollment of Pivotal U.S. FDA IDE Study for its P-15L Bone Graft byChris StewartFebruary 24, 2022
Spine Top Stories Orthofix Announces US Launch and First Patient Implants with New fiberFUSE Strip – An Advanced Fiber Bone-Graft Solution Containing Cancellous Bone byJosh SandbergJuly 28, 2021
